Metraipolis › archive › dc_0bcb747eb617
Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins — Europe PMC PMID:31697791
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/31697791
- DOI
- 10.1371/journal.ppat.1008061
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-10T02:58:12.194Z
- SHA-256 of the archived text
a9b94a6e2351fe8dea0817e459a465c7d8fd8e89619d44dbbfe37f9a6be58b8b- Stable URL of this page
https://metraipolis.com/documento/dc_0bcb747eb617
How to cite
Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins — Europe PMC PMID:31697791 — Europe PMC (en), https://europepmc.org/article/MED/31697791 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_0bcb747eb617 (Metraipolis archive dc_0bcb747eb617, sha256 a9b94a6e2351fe8dea0817e459a465c7d8fd8e89619d44dbbfe37f9a6be58b8b)
BibTeX
@misc{dc0bcb747eb617,
title = {Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins — Europe PMC PMID:31697791},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/31697791},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_0bcb747eb617; sha256 a9b94a6e2351fe8dea0817e459a465c7d8fd8e89619d44dbbfe37f9a6be58b8b},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/31697791. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that causes persistent arthritis in a subset of human patients. We report the isolation and functional characterization of monoclonal antibodies (mAbs) from two patients infected with CHIKV in the Dominican Republic. Single B cell sorting yielded a panel of 46 human mAbs of diverse germline lineages that targeted epitopes within the E1 or E2 glycoproteins. MAbs that recognized either E1 or E2 proteins exhibited neutralizing activity. Viral escape mutations localized the binding epitopes for two E1 mAbs to sites within domain I or the linker between domains I and III; and for two E2 mAbs between the β-connector region and the B-domain. Two of the E2-specific mAbs conferred protection in vivo in a stringent lethal challenge mouse model of CHIKV infection, whereas the E1 mAbs did not. These results provide insight into human antibody response to CHIKV and identify candidate mAbs for therapeutic intervention. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS pathogens, 2019 (prima pubblicazione 2019-11-07). Identificativi: PMID 31697791 · PMCID PMC6837291 · DOI 10.1371/journal.ppat.1008061. Pagina: https://europepmc.org/article/MED/31697791 — https://doi.org/10.1371/journal.ppat.1008061. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-10T02:55:05.545Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.